TABLE 2.

DT and TT protein content administered at each visit^a

Study	Protein content (μg)
	DT				TT
	PncD/T11	DTPb	PRP-T	Total	PncD/T11	DTP	PRP-T	Total
Study 1	64	105	—c	169	12	33	24	69
Study 2	59	105	—	164	14	33	24	71
Study 3
PncD/T11 group	59	52	—	111	17	17	24	58
Concomitant vaccine-only group	—	52	—	52	—	17	24	41

^aAges 2, 4, 6, and 12 months.

^bIn studies 1 and 2, DTwP; in study 3, DTaP.

^c—, not relevant.